Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy does not directly speed up metabolism in the way a stimulant would. What semaglutide does is reduce appetite and slow the rate at which your stomach empties, so you eat less without fighting hunger as hard. Weight loss then follows, and that loss carries its own metabolic consequences — some helpful, some worth knowing about. These are prescription-only medicines: a prescriber assesses whether they are suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is one of the questions our prescribers hear most weeks, and the honest answer is: not in the direct sense people usually mean. When most people ask whether Wegovy speeds up metabolism, they are picturing something that makes the body burn calories faster at rest, the way caffeine or thyroid hormone can. Semaglutide does not work like that.
What it does is activate GLP-1 receptors in the gut and brain. This slows gastric emptying, so food sits in the stomach longer and fullness signals travel to the brain more persistently. The result is a genuine, sustained reduction in appetite and calorie intake. Over time, eating less than your body needs produces weight loss. The mechanism is appetite and intake, not a raised metabolic rate. If you want to explore how semaglutide interacts with metabolism more broadly, that piece goes deeper into the hormonal pathway involved.
The NHS medicines information for semaglutide confirms this: the drug acts on appetite regulation, not on resting energy expenditure directly. That distinction matters for setting realistic expectations. You are not getting a metabolic boost; you are getting a powerful reduction in the drive to overeat, which is arguably more useful and certainly more sustained.
Here is where the picture becomes more nuanced. When anyone loses a significant amount of weight, the body's resting metabolic rate falls. This is adaptive thermogenesis, the body defending its previous state. It happens whether you lose weight through diet alone, surgery, or GLP-1 treatment. It is not a Wegovy-specific side effect; it is a physiological response to weighing less.
The practical implication is that, over the course of treatment, your calorie needs will be somewhat lower than they were at your starting weight. Some people interpret this as the medicine slowing their metabolism, but it is more accurate to say that a lighter body burns fewer calories at rest. Research published in the STEP 1 trial in the New England Journal of Medicine showed around 15% average weight reduction over 68 weeks at the 2.4mg maintenance dose, a result that reflects sustained appetite suppression rather than any thermogenic effect.
There is a separate question about whether Wegovy preserves lean muscle mass better than calorie restriction alone. Early evidence is encouraging, though the picture is still developing. What is clear is that protein intake and resistance exercise both matter during treatment, they help protect the muscle you have, which in turn supports a healthier resting metabolic rate. Your prescriber can point you towards practical guidance on this.
Semaglutide targets one receptor: GLP-1. Tirzepatide (the active ingredient in Mounjaro) targets two, GLP-1 and GIP. Some researchers believe the dual-receptor action produces modestly different effects on fat metabolism and energy expenditure, though the clinical evidence in humans is still limited on this specific point. What the head-to-head SURMOUNT-5 trial showed is that tirzepatide produced greater average weight loss than semaglutide 2.4mg over 72 weeks. Whether that reflects a difference in metabolic action or simply stronger appetite suppression is still being unpacked.
If you are weighing up the two options, the Wegovy overview page and the semaglutide page both cover the licensed indications and trial evidence in full. For a broader look at how treatment fits into a weight management plan, the weight loss treatment overview is a good place to start. The right choice between them depends on your clinical picture, not on metabolism theories alone.
Three things hold up well across the evidence. First, eat enough protein. Appetite suppression from semaglutide can sometimes make it easy to undereat (particularly protein) which speeds up the loss of lean muscle. Aim for adequate protein at each meal even when hunger is low. Second, keep moving, and include some resistance work if you can. Muscle tissue is metabolically active; maintaining it is the most reliable way to keep resting energy expenditure from falling further than it needs to. Third, think of treatment as a window, not a solution by itself. The appetite suppression Wegovy provides gives you a real opportunity to build habits that support your metabolism long-term.
Cost is a practical factor in how long people can stay on treatment. The UK cost context for Wegovy explains how private pricing is structured and what a legitimate prescription service includes. For a full look at what affects how Wegovy works in the body, including absorption factors, this page on semaglutide absorption covers the detail. And if your question is more specifically about whether Wegovy slows metabolism during or after treatment, that question has its own dedicated answer.
Wegovy is a prescription-only medicine. Whether it is right for you depends on your health history, current medications, and clinical assessment. If you would like a prescriber to review your situation, speak to our prescribers, consultations are free, and every review is done by a GPhC-registered Independent Prescriber the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.